Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle-invasive bladder cancer (NMIBC) accounts for roughly 75% of all bladder cancer cases. For patients with intermediate- and high-risk disease, intravesical Bacillus Calmette-Guérin (BCG) remains the standard treatment, yet it fails in up to 40% of cases. While radical cystectomy is the most...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
IMR Press
2026-04-01
|
| Collection: | Frontiers in Bioscience-Landmark |
| Sujets: | |
| Accès en ligne: | https://www.imrpress.com/journal/FBL/31/5/10.31083/FBL47606 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|